- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/12 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
Patent holdings for IPC class C07D 215/12
Total number of patents in this class: 446
10-year publication summary
|
25
|
26
|
26
|
41
|
24
|
32
|
22
|
20
|
26
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5831 |
12 |
| Bristol-myers Squibb Company | 4898 |
10 |
| The Regents of the University of California | 19918 |
6 |
| Ohio State Innovation Foundation | 2132 |
6 |
| Sun Pharma Advanced Research Company Ltd. | 198 |
6 |
| Hendrix College | 16 |
6 |
| VALO Health, Inc. | 172 |
6 |
| Katholieke Universiteit Leuven | 1191 |
5 |
| The Scripps Research Institute | 1346 |
5 |
| Vib VZW | 876 |
5 |
| Agc, Inc. | 4839 |
5 |
| Shaanxi Lighte Optoelectronics Material Co., Ltd. | 259 |
5 |
| Novartis AG | 10849 |
4 |
| Samsung Display Co., Ltd. | 34696 |
4 |
| Janssen Pharmaceutica N.V. | 3392 |
4 |
| Toray Industries, Inc. | 6936 |
4 |
| The Board of Regents of the University of Texas System | 2206 |
4 |
| SpringWorks Therapeutics, Inc. | 126 |
4 |
| The Royal Institution for The Advancement of Learning / McGill University | 689 |
4 |
| F. Hoffmann-La Roche AG | 7925 |
3 |
| Other owners | 338 |